Treatment of Portal Hypertension with Hyponatremia in Cirrhosis

Clinical Scenario

This protocol addresses portal hypertension in patients with liver cirrhosis who develop hyponatremia — most commonly of the hypervolemic type. Hypervolemia is the predominant mechanism driving sodium derangement in this population.

Management Approach

In patients with symptomatic hyponatremia and critically low serum sodium levels, a specific intravenous corrective intervention may be considered — applied cautiously, with careful attention to the daily rate of sodium correction to avoid overcorrection.

The complete evidence-based regimen, including precise thresholds, selection criteria, and monitoring parameters, is available in the full protocol.

▶

Primary Goal Controlled increase in serum sodium, not exceeding 8 mEq per day.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.jceh.2022.03.002

Hypervolemia is the most common cause of hyponatremia in patients with cirrhosis.

However, in patients with symptomatic hyponatremia with serum sodium <120 mEq/L or serum sodium <110 mEq/L, the cautious use of hypertonic saline is suggested with a target to increase serum sodium by ≤ 8 mEq per day.

View source ↗